160 related articles for article (PubMed ID: 37584729)
1. Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma.
Saito T; Muragaki Y; Komori A; Nitta M; Tsuzuki S; Koriyama S; Ro B; Kawamata T
Neurosurg Rev; 2023 Aug; 46(1):202. PubMed ID: 37584729
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
Gállego Pérez-Larraya J; Paris S; Idbaih A; Dehais C; Laigle-Donadey F; Navarro S; Capelle L; Mokhtari K; Marie Y; Sanson M; Hoang-Xuan K; Delattre JY; Mallet A
Cancer; 2014 Dec; 120(24):3972-80. PubMed ID: 25139333
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
Kefayat A; Amouheidari A; Ghahremani F; Alirezaei Z
Cancer Med; 2021 Aug; 10(15):5154-5162. PubMed ID: 34250760
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma.
Marfia G; Navone SE; Fanizzi C; Tabano S; Pesenti C; Abdel Hadi L; Franzini A; Caroli M; Miozzo M; Riboni L; Rampini P; Campanella R
Cancer Med; 2016 Aug; 5(8):1783-90. PubMed ID: 27236861
[TBL] [Abstract][Full Text] [Related]
6. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
Ohno M; Matsuzaki J; Kawauchi J; Aoki Y; Miura J; Takizawa S; Kato K; Sakamoto H; Matsushita Y; Takahashi M; Miyakita Y; Ichimura K; Narita Y; Ochiya T
JAMA Netw Open; 2019 Dec; 2(12):e1916953. PubMed ID: 31808923
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
[TBL] [Abstract][Full Text] [Related]
10. Mucosal thickening of the maxillary sinus is frequently associated with diffuse glioma patients and correlates with poor survival prognosis of GBM patients: comparative analysis to meningioma patients.
Saito T; Muragaki Y; Maruyama T; Abe K; Komori T; Amano K; Eguchi S; Nitta M; Tsuzuki S; Fukui A; Kawamata T
Neurosurg Rev; 2021 Dec; 44(6):3249-3258. PubMed ID: 33537891
[TBL] [Abstract][Full Text] [Related]
11. Impact of a novel biomarker, T-LAK cell-originating protein kinase (TOPK) expression on outcome in malignant glioma.
Hayashi T; Hayakawa Y; Koh M; Tomita T; Nagai S; Kashiwazaki D; Sugimori M; Origasa H; Kuroda S
Neuropathology; 2018 Apr; 38(2):144-153. PubMed ID: 29271010
[TBL] [Abstract][Full Text] [Related]
12. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
[TBL] [Abstract][Full Text] [Related]
13. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
Chen J; Yang L; Wang X
Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553
[TBL] [Abstract][Full Text] [Related]
14. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
15. Prognosis and management of gliosarcoma patients: A review of literature.
Saadeh F; El Iskandarani S; Najjar M; Assi HI
Clin Neurol Neurosurg; 2019 Jul; 182():98-103. PubMed ID: 31112812
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of preoperative controlling nutritional status in patients with glioblastoma.
Hu C; Chen K; Tang X
Clin Neurol Neurosurg; 2020 Nov; 198():106129. PubMed ID: 32823182
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA-137 is a potential biomarker for human glioblastoma.
Li HY; Li YM; Li Y; Shi XW; Chen H
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3599-604. PubMed ID: 27649660
[TBL] [Abstract][Full Text] [Related]
18. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
Wang Q; Li P; Li A; Jiang W; Wang H; Wang J; Xie K
J Exp Clin Cancer Res; 2012 Nov; 31(1):97. PubMed ID: 23174013
[TBL] [Abstract][Full Text] [Related]
19. Soluble cytotoxic T-lymphocyte-associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma.
Liu J; Tian X; Wang Y; Kang X; Song W
BMC Immunol; 2021 May; 22(1):33. PubMed ID: 34006227
[TBL] [Abstract][Full Text] [Related]
20. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]